Pictet & Cie (Europe) Sa Dexcom Inc Transaction History

Pictet & Cie (Europe) Sa

$4.64 Billion
Q2 2025

A detailed history of Pictet & Cie (Europe) Sa transactions in Dexcom Inc stock. As of the latest transaction made, Pictet & Cie (Europe) Sa holds 150,642 shares of DXCM stock, worth $13.1 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

150,642

Previous 117,575 28.12%

Holding current value

$13.1 Million

Previous $8.03 Million 63.77%

% of portfolio

0.28%

Previous 0.19%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 16, 2025	BUY	$59.83 - $87.57 $1.98 Million - $2.9 Million	33,067 Added 28.12%	150,642 $13.1 Million
Q1 2025 Apr 17, 2025	BUY	$67.74 - $90.75 $441,122 - $590,964	6,512 Added 5.86%	117,575 $8.03 Million
Q4 2024 Jan 30, 2025	BUY	$65.68 - $81.01 $132,016 - $162,830	2,010 Added 1.84%	111,063 $8.64 Million
Q3 2024 Oct 22, 2024	BUY	$64.0 - $116.06 $1.56 Million - $2.83 Million	24,411 Added 28.84%	109,053 $7.31 Million
Q2 2024 Jul 25, 2024	BUY	$110.31 - $140.45 $1.36 Million - $1.73 Million	12,318 Added 17.03%	84,642 $9.6 Million
Q1 2024 May 07, 2024	BUY	$114.22 - $140.1 $3.68 Million - $4.51 Million	32,212 Added 80.31%	72,324 $10 Million
Q4 2023 Feb 09, 2024	SELL	$75.49 - $124.16 $290,259 - $477,395	-3,845 Reduced 8.75%	40,112 $4.98 Million
Q3 2023 Nov 02, 2023	BUY	$86.06 - $137.93 $3.39 Million - $5.43 Million	39,394 Added 863.34%	43,957 $4.1 Million
Q2 2023 Aug 08, 2023	BUY	$112.47 - $130.98 $248,558 - $289,465	2,210 Added 93.92%	4,563 $586,000
Q1 2023 May 01, 2023	SELL	$104.0 - $122.92 $170,664 - $201,711	-1,641 Reduced 41.09%	2,353 $273,000
Q4 2022 Feb 08, 2023	SELL	$84.98 - $122.67 $84,130 - $121,443	-990 Reduced 19.86%	3,994 $0
Q2 2022 Aug 05, 2022	BUY	$67.99 - $132.89 $213,692 - $417,673	3,143 Added 170.72%	4,984 $371,000
Q1 2022 May 04, 2022	BUY	$94.08 - $130.2 $35,938 - $49,736	382 Added 26.18%	1,841 $942,000
Q4 2021 Feb 02, 2022	BUY	$129.87 - $162.82 $21,818 - $27,353	168 Added 13.01%	1,459 $783,000
Q3 2021 Nov 10, 2021	SELL	$106.71 - $143.18 $475,606 - $638,153	-4,457 Reduced 77.54%	1,291 $706,000
Q2 2021 Aug 11, 2021	BUY	$80.99 - $107.93 $22,839 - $30,436	282 Added 5.16%	5,748 $2.45 Million
Q1 2021 May 10, 2021	BUY	$84.79 - $104.74 $126,676 - $156,481	1,494 Added 37.61%	5,466 $1.96 Million
Q4 2020 Feb 11, 2021	BUY	$78.0 - $104.5 $309,816 - $415,074	3,972 New	3,972 $1.47 Million
Q2 2018 Aug 10, 2018	SELL	$17.54 - $25.22 $91,506 - $131,572	-5,217 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$13.06 - $18.54 $7,666 - $10,882	587 Added 12.68%	5,217 $387,000
Q4 2017 Feb 09, 2018	BUY	$11.12 - $15.38 $51,485 - $71,209	4,630	4,630 $266,000

Others Institutions Holding DXCM

# of Institutions

1,084

Shares Held

363M

Call Options Held

5.4M

Put Options Held

4.3M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.

Account

Pictet & Cie (Europe) Sa Dexcom Inc Transaction History